Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Small financial incentives boost HBV uptake among drug users

  • Comment

Small financial incentives, of as little as £30, could encourage injecting drug users to complete a course of hepatitis B virus (HBV) vaccination, according to researchers.

A new study published in The Lancet found heroin users who received a maximum total of £30 supermarket vouchers in equal or graduated instalments in return for full compliance with a regimen of three HBV vaccine injections were at least 12 times as likely to complete the course within 28 days, compared with those not receiving a financial incentive.

“The size of the increase we observed was striking”

John Strang

The study was led by Professor John Strang from the National Addiction Centre at King’s College London, which also included researchers at Imperial College London and University College London.

“That monetary incentives increase compliance is unremarkable, but the size of the increase we observed was striking,” said Professor Strang.

“Injecting drug users are at high risk of infection and transmission of hepatitis B. This is a potentially life-saving vaccine, and increasing its uptake among this group has important benefits to public health, as well as to the individual.”

HBV affects about 22% of injecting drug users in the UK. Medication can slow the spread of the virus, although there is no completely effective cure.

It is estimated that 15%-25% of people with untreated chronic HBV die of liver disease. A highly effective vaccine exists, but the rate of vaccination uptake is poor.

John Strang

John Strang

The researchers randomly assigned 210 patients into three groups: HBV vaccination without incentive, fixed value contingency management (£10 voucher at each of three vaccinations), or escalating value contingency management (£5 voucher at first vaccination visit, £10 voucher at second visit, and £15 voucher at third visit).

Only 9% of 67 participants in the treatment as usual group completed all scheduled vaccinations, compared with 45% of 78 participants in the fixed reward group, and 49% of 65 participants in the escalating reward group.

Some 80% of participants receiving financial incentives also attended appointments on time, ensuring a more efficient use of resources.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs